Diabetes Stocks in Market
A supplementary factor fueling the increase of diabetes in the United States is the quick growth of the Hispanic section of our population. Of those people who are stricken with diabetes, Latino Americans are for the most part at risk as they show a very high prevalence of the illness. Hispanics are now the largest and fastest growing minority in the United States according to the most recent U.S. census data. Couple this fact with the pronouncement that Mexican-American children and teenagers are more than two times as likely as non-Hispanic whites to be overweight and you have a recipe for augmented diabetes development. As the Latino presence in the U.S. keeps on growing, the prevalence of diabetes will keep growing.
The treatment of diabetes and its connected complications have turned out to be big business in the United States. Medical expenditures for diabetic patients are 2.4 times higher than those of non-diabetic patients. Healthcare costs which are related to the treatment of diabetes are estimated to grow to $156 billion by the year 2010. This estimate is close to $200 billion by the year 2020. The kicker is that those numbers don't even adjust for inflation!
